CN107202888B - 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 - Google Patents
一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 Download PDFInfo
- Publication number
- CN107202888B CN107202888B CN201710562392.4A CN201710562392A CN107202888B CN 107202888 B CN107202888 B CN 107202888B CN 201710562392 A CN201710562392 A CN 201710562392A CN 107202888 B CN107202888 B CN 107202888B
- Authority
- CN
- China
- Prior art keywords
- ink4a
- liquid
- cervical
- antibody
- reagent box
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 80
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 25
- 239000000427 antigen Substances 0.000 claims abstract description 24
- 239000007853 buffer solution Substances 0.000 claims abstract description 21
- 239000000243 solution Substances 0.000 claims abstract description 19
- 239000002981 blocking agent Substances 0.000 claims abstract description 16
- 239000013642 negative control Substances 0.000 claims abstract description 15
- 239000013558 reference substance Substances 0.000 claims abstract description 13
- 230000014509 gene expression Effects 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 14
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 11
- 229920002866 paraformaldehyde Polymers 0.000 claims description 11
- 238000004321 preservation Methods 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 210000003679 cervix uteri Anatomy 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 6
- 208000034254 Squamous cell carcinoma of the cervix uteri Diseases 0.000 claims description 6
- 201000006612 cervical squamous cell carcinoma Diseases 0.000 claims description 6
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 5
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims description 5
- 239000008363 phosphate buffer Substances 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 235000011330 Armoracia rusticana Nutrition 0.000 claims description 2
- 240000003291 Armoracia rusticana Species 0.000 claims description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- OQUFOZNPBIIJTN-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;sodium Chemical compound [Na].OC(=O)CC(O)(C(O)=O)CC(O)=O OQUFOZNPBIIJTN-UHFFFAOYSA-N 0.000 claims 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 1
- LLJZKKVYXXDWTB-UHFFFAOYSA-N acetic acid;sodium Chemical compound [Na].[Na].CC(O)=O LLJZKKVYXXDWTB-UHFFFAOYSA-N 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 21
- 238000010186 staining Methods 0.000 abstract description 8
- 108091007433 antigens Proteins 0.000 abstract description 7
- 102000036639 antigens Human genes 0.000 abstract description 7
- 230000007170 pathology Effects 0.000 abstract description 4
- 238000004040 coloring Methods 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 51
- 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 17
- 208000019065 cervical carcinoma Diseases 0.000 description 14
- 241000701806 Human papillomavirus Species 0.000 description 13
- 238000004140 cleaning Methods 0.000 description 12
- 230000003053 immunization Effects 0.000 description 9
- 238000002649 immunization Methods 0.000 description 9
- 238000011534 incubation Methods 0.000 description 8
- 230000003902 lesion Effects 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000004043 dyeing Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 description 2
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000037581 Persistent Infection Diseases 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 238000009595 pap smear Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 230000010190 G1 phase Effects 0.000 description 1
- 101000733249 Homo sapiens Tumor suppressor ARF Proteins 0.000 description 1
- 241000780272 Mammilla Species 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 101710132595 Protein E7 Proteins 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 108700025695 Suppressor Genes Proteins 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046940 Vaginal prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- JGGQWILNAAODRS-UHFFFAOYSA-N n-methyl-4-[4-(methylamino)phenyl]aniline Chemical compound C1=CC(NC)=CC=C1C1=CC=C(NC)C=C1 JGGQWILNAAODRS-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710562392.4A CN107202888B (zh) | 2017-07-11 | 2017-07-11 | 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710562392.4A CN107202888B (zh) | 2017-07-11 | 2017-07-11 | 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107202888A CN107202888A (zh) | 2017-09-26 |
CN107202888B true CN107202888B (zh) | 2018-10-12 |
Family
ID=59911625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710562392.4A Active CN107202888B (zh) | 2017-07-11 | 2017-07-11 | 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107202888B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110763661B (zh) * | 2018-07-25 | 2022-03-22 | 中国科学院合肥物质科学研究院 | 处理液组合物、试剂盒和生物器官透明化同时进行免疫标记的方法 |
CN110501496A (zh) * | 2019-08-28 | 2019-11-26 | 深圳市森盈生物科技有限公司 | 一种免疫细胞p16检测试剂盒 |
CN110488001A (zh) * | 2019-09-11 | 2019-11-22 | 广州江元医疗科技有限公司 | 一种使用密度梯度分层离心法进行抗原修复的方法 |
CN112710526A (zh) * | 2019-10-24 | 2021-04-27 | 广州江元医疗科技有限公司 | 一种细胞固定保存液及其制备方法和应用 |
CN111024471A (zh) * | 2019-12-17 | 2020-04-17 | 浙江殷欣生物技术有限公司 | 一种用于宫颈癌筛查的液基细胞检测试剂盒及使用方法 |
CN112114145A (zh) * | 2020-09-21 | 2020-12-22 | 中山大学附属第一医院 | 一种检测hpv病毒感染致宫颈癌的试剂盒 |
CN112180090A (zh) * | 2020-10-09 | 2021-01-05 | 深圳市森盈生物科技有限公司 | 免疫细胞p16特异性结合的单克隆抗体的试剂盒 |
CN113607534B (zh) * | 2021-08-20 | 2022-10-18 | 河南赛诺特生物技术有限公司 | 一种染色方法、试剂盒及应用 |
CN114152493A (zh) * | 2021-11-12 | 2022-03-08 | 杭州迪英加科技有限公司 | 一种用于石蜡切片的低ph脱蜡修复阻断溶液及其配置方法 |
CN116380602B (zh) * | 2023-06-05 | 2023-09-08 | 深圳市森盈生物科技有限公司 | 一种液基细胞学和免疫细胞化学双制片染色试剂盒及应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101446591A (zh) * | 2008-11-15 | 2009-06-03 | 邹先进 | P16INK4a双抗体夹心酶联免疫吸附检测试剂盒 |
CN102258003A (zh) * | 2010-05-28 | 2011-11-30 | 孝感市中心医院 | 一种液基细胞保存液 |
CN101914483B (zh) * | 2010-09-02 | 2013-07-31 | 福建新大陆生物技术股份有限公司 | 一种液基薄层细胞保存处理液及其用途 |
CN102113481B (zh) * | 2010-12-24 | 2013-03-13 | 厦门迈威生物科技有限公司 | 一种脱落细胞保存液及其制备方法 |
CN102318597B (zh) * | 2011-08-19 | 2013-04-03 | 张雪云 | 一种液基细胞保存液组合物及其制备方法 |
CN103120153A (zh) * | 2012-11-26 | 2013-05-29 | 刘召宏 | 一种脱落细胞保存液 |
CN103076453B (zh) * | 2012-12-24 | 2015-04-15 | 何以丰 | P16免疫细胞化学试剂盒及其制备用多肽序列 |
CN104155167A (zh) * | 2013-05-27 | 2014-11-19 | 厦门菲尔科生物技术有限公司 | 低背景的P16-INK4a染色试剂盒及其应用方法 |
CN104041484B (zh) * | 2014-05-23 | 2016-09-28 | 科蒂亚(新乡)生物技术有限公司 | 一种细胞保存液 |
CN106442078B (zh) * | 2016-08-25 | 2019-09-10 | 四川金域医学检验中心有限公司 | 一种碱性液基细胞保存处理液及其制备方法 |
-
2017
- 2017-07-11 CN CN201710562392.4A patent/CN107202888B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107202888A (zh) | 2017-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107202888B (zh) | 一种用于宫颈液基细胞的p16INK4a免疫标记显色试剂盒 | |
CN102822672B (zh) | 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定 | |
CN104067126B (zh) | 用于检测人乳头瘤病毒并提供头颈部鳞状细胞癌预后的方法 | |
CN109856383A (zh) | 一种用于宫颈癌辅助诊断的免疫化学染色试剂盒 | |
CN103033409B (zh) | 改进的组织细胞染色方法及其应用 | |
CN109187978A (zh) | 一种检测循环肿瘤细胞her2、er、pr的免疫荧光试剂盒及其应用 | |
Sarian et al. | Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix | |
CN110275028A (zh) | 一种胶体金标记的抗he4抗体试剂盒及其制备方法 | |
CN101446591A (zh) | P16INK4a双抗体夹心酶联免疫吸附检测试剂盒 | |
CN109187977A (zh) | 一种检测her2抗原不同位点的免疫荧光试剂盒及应用 | |
CN104745670A (zh) | 一种细胞芯片的制备方法及其在肿瘤筛查领域的应用 | |
CN107271246B (zh) | 一种用于液基薄层细胞的免疫p16INK4a抗原保存液及其制备方法 | |
CN109425527B (zh) | 一种细胞染色方法 | |
CN101968491A (zh) | 弥漫性大b细胞淋巴瘤分子病理分型方法及试剂盒和应用 | |
Dai et al. | Effectiveness of novel folate receptor-mediated staining solution detection (FRD) for cervical cancer screening | |
CN103471903A (zh) | 切片用固定液的配置方法及其应用 | |
CN105241726A (zh) | 一种免疫细胞化学染色方法及其在宫颈肿瘤性病变筛查中的应用 | |
Sartelet et al. | Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma | |
Namugenyi et al. | Prevalence and genotype distribution of human papillomavirus in cytology specimens containing atypical glandular cells: A case–control study | |
CN103966360B (zh) | 一种人乳头状瘤病毒16/18的检测方法、检测试剂盒和hpv16/18探针 | |
CN102435734A (zh) | 卵巢癌原发化疗敏感性测评试剂盒及其应用 | |
CN106610378A (zh) | 一种hpv16型e7蛋白的检测试剂盒 | |
CN104849449A (zh) | 酶标抗体-金纳米探针在二氨基联苯胺催化显色及暗场成像的应用 | |
CN205049576U (zh) | 一种用于检测乳腺癌细胞的染色试剂盒 | |
Hatta et al. | Freshly prepared immune complexes with intermittent microwave irradiation result in rapid and high-quality immunostaining |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A p16INK4aimmunolabeling kit for cervical fluid based cells Effective date of registration: 20201013 Granted publication date: 20181012 Pledgee: Shanghai Pudong Development Bank Limited by Share Ltd. Guangzhou branch Pledgor: GUANGZHOU JIANGYUAN MEDICAL SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: Y2020440000307 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211022 Granted publication date: 20181012 Pledgee: Shanghai Pudong Development Bank Limited by Share Ltd. Guangzhou branch Pledgor: GUANGZHOU JIANGYUAN MEDICAL SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: Y2020440000307 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: P16INK4aimmunolabeling chromogenic kit for cervical fluid based cells Effective date of registration: 20211118 Granted publication date: 20181012 Pledgee: Shanghai Pudong Development Bank Limited by Share Ltd. Guangzhou branch Pledgor: GUANGZHOU JIANGYUAN MEDICAL SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: Y2021440000346 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230116 Granted publication date: 20181012 Pledgee: Shanghai Pudong Development Bank Limited by Share Ltd. Guangzhou branch Pledgor: GUANGZHOU JIANGYUAN MEDICAL SCIENCE & TECHNOLOGY Co.,Ltd. Registration number: Y2021440000346 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |